Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Vella

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Antimicrobial Agents and Chemotherapy|September 29, 2006
Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compoundsRoberta Bona, Mauro Andreotti, Viviana Buffa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 21, 2018
Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or RaltegravirElizabeth C George, Raffaella Bucciardini, Laura Richert, et al.
Annali Dell'Istituto Superiore Di Sanita|December 19, 2019
Health and Climate Change: science calls for global actionWalter Ricciardi, Stefania Marcheggiani, Camilla Puccinelli, et al.
AIDS Research and Human Retroviruses|August 9, 2014
Viral sequence analysis of HIV-positive women and their infected children: insight on the timing of infection and on the transmission networkMassimo Ciccozzi, Alessandra Lo Presti, Mauro Andreotti, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in MalawiLeonardo Palombi, Maria F Pirillo, Emilia Marchei, et al.
Plos One|October 24, 2014
Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trialGabriella d'Ettorre, Silvia Baroncelli, Luca Micci, et al.
The Journal of Infectious Diseases|August 23, 2003
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus diseaseMargaret A Fischl, Heather J Ribaudo, Ann C Collier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) studyLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.
BMJ Global Health|October 31, 2017
Predictors of attrition from care at 2 years in a prospective cohort of HIV-infected adults in Tigray, EthiopiaRaffaella Bucciardini, Vincenzo Fragola, Teshome Abegaz, et al.
Peptides|May 25, 2010
Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substancesStefano Loizzo, Stefano Vella, Alberto Loizzo, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|September 29, 2006
Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compoundsRoberta Bona, Mauro Andreotti, Viviana Buffa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 21, 2018
Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or RaltegravirElizabeth C George, Raffaella Bucciardini, Laura Richert, et al.
Annali Dell'Istituto Superiore Di Sanita|December 19, 2019
Health and Climate Change: science calls for global actionWalter Ricciardi, Stefania Marcheggiani, Camilla Puccinelli, et al.
AIDS Research and Human Retroviruses|August 9, 2014
Viral sequence analysis of HIV-positive women and their infected children: insight on the timing of infection and on the transmission networkMassimo Ciccozzi, Alessandra Lo Presti, Mauro Andreotti, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in MalawiLeonardo Palombi, Maria F Pirillo, Emilia Marchei, et al.
Plos One|October 24, 2014
Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trialGabriella d'Ettorre, Silvia Baroncelli, Luca Micci, et al.
The Journal of Infectious Diseases|August 23, 2003
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus diseaseMargaret A Fischl, Heather J Ribaudo, Ann C Collier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) studyLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.
BMJ Global Health|October 31, 2017
Predictors of attrition from care at 2 years in a prospective cohort of HIV-infected adults in Tigray, EthiopiaRaffaella Bucciardini, Vincenzo Fragola, Teshome Abegaz, et al.
Peptides|May 25, 2010
Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substancesStefano Loizzo, Stefano Vella, Alberto Loizzo, et al.
Pageof 16